Category
144 releases
New education initiative aims to expand awareness of DBS and empower people with Parkinson's to make informed decisions about their treatment options…
Gan & Lee Pharmaceuticals (Stock Code: 603087. SH) announced positive topline results from GRADUAL-3, a Phase III clinical study evaluating…
In this free webinar, learn how early-stage oncology programs can integrate Western and Asian markets into a global development strategy. The…
Collaboration will initially apply blood-based circular RNA profiling to LM11A-31 in Alzheimer's disease, with potential expansion across…
-- Presented additional 36-week results and 16-week off-drug findings from Part B of the SIGNAL-AA clinical trial of bempikibart in late-breaking…
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that on November 2, 2026, its Board of Directors declared a quarterly…
Execution of Three-S plan driving sequential improvement in operating results and market share gains across U.S. Store Brand OTC and key European…
Prevention approach aims to keep patients on immune checkpoint inhibitor (ICI) therapy and avoid immunosuppressive irEC treatments, representing an…
A leading healthcare solutions company with health benefits, pharmacy services and care delivery The leading national retail pharmacy and community…
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to…
Instrument operational at the Suzhou R&D center, with MicroED built into solid-form screening and results in as little as 48 hours SUZHOU, China,…
New study replicates ingredient's bifidogenic effect, stool form outcomes, and tolerability. CARBERRY, MB, Nov. 4, 2026 — MSP Starch Products Inc.,…
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it…
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,…
Modern radiotherapy for prostate cancer is as effective as surgery with important advantages in preservation of urinary continence and sexual…
Findings build on TJ Biopharma's pioneering work on GM-CSF as a therapeutic target in macrophage- and myeloid cell-driven inflammation Phase 2…
International network of researchers, clinicians and scientific leaders will unite expertise across dentistry, medicine, microbiology, immunology and…
Global Debut at EuroTier 2026 SEOUL, South Korea, Nov. 4, 2026 — CJ BIO will unveil NewtriSolution™ at EuroTier 2026, a web-based animal nutrition…
Minghui Pharmaceutical ("Minghui") and ASKA Pharmaceutical Co., Ltd. ("ASKA") today announced that they have entered into an exclusive license…
IASO Bio and its Singapore partner Pills and Pokes jointly hosted the FUCASO launch event in Singapore on November 3, marking the official commercial…
